about
Efficacy of Eculizumab Therapy for Atypical Hemolytic Uremic Syndrome Recurrence and Antibody-Mediated Rejection Progress After Renal Transplantation With Preformed Donor-Specific Antibodies: Case Report.A Retrospective Study of the Impact of Intraoperative Intact Parathyroid Hormone Monitoring During Total Parathyroidectomy for Secondary Hyperparathyroidism: STARD StudyManagement of Pneumocystis jirovecii Pneumonia in Kidney Transplantation to Prevent Further Outbreak.Association of Dialysis Duration with Outcomes after Transplantation in a Japanese Cohort.Impact of Arterial Reconstruction With Recipient's Own Internal Iliac Artery for Multiple Graft Arteries on Living Donor Kidney Transplantation: Strobe StudyImpact of grafting using thin upper pole artery ligation on living-donor adult kidney transplantation: The STROBE study.Encephalitis caused by human herpesvirus-6B in pancreas-after-kidney transplantation.Favorable results in ABO-incompatible renal transplantation without B cell-targeted therapy: Advantages and disadvantages of rituximab pretreatment.Characteristics of Persistent Hyperparathyroidism After Renal Transplantation.5-year follow-up of a randomized clinical study comparing everolimus plus reduced-dose cyclosporine with mycophenolate mofetil plus standard-dose cyclosporine in de novo kidney transplantation: Retrospective single center assessment.Death and kidney allograft dysfunction after bacteremia.Potent immunosuppression for ABO-incompatible renal transplantation may not be a risk factor for malignancy.Neither pre-transplant rituximab nor splenectomy affects de novo HLA antibody production after renal transplantation.MiR-142-5p and miR-486-5p as biomarkers for early detection of chronic antibody-mediated rejection in kidney transplantation.De Novo Anti-HLA DSA Characteristics and Subclinical Antibody-Mediated Kidney Allograft Injury.Location Frequency of Missed Parathyroid Glands After Parathyroidectomy in Patients with Persistent or Recurrent Secondary Hyperparathyroidism.Beneficial effects of preemptive kidney transplantation on calcium and phosphorus disorders in early post-transplant recipients.Acute antibody-mediated rejection possibly due to anti-human leukocyte antigen DQB1 antibodies after renal transplantation - case report.Frequent development of subclinical chronic antibody-mediated rejection within 1 year after renal transplantation with pre-transplant positive donor-specific antibodies and negative CDC crossmatches.Significance of C4d deposition in antibody-mediated rejection.Clinical characteristics and outcomes of renal transplantation in elderly recipients.Tertiary hyperparathyroidism resistant to cinacalcet treatment.Role of multifunctional cell cycle modulators in advanced secondary hyperparathyroidism.B cell phenotypes in baboons with pig artery patch grafts receiving conventional immunosuppressive therapyDecreased glomerular filtration as the primary factor of elevated circulating suPAR levels in focal segmental glomerulosclerosisSkin xenotransplantation: Historical review and clinical potentialSurgical Techniques and Procedures for Kidney Transplant Recipients With Severe AtherosclerosisSerum amyloid a as an indicator of impending xenograft failure: Experimental studiesIs interleukin-6 receptor blockade (tocilizumab) beneficial or detrimental to pig-to-baboon organ xenotransplantation?Indicators of impending pig kidney and heart xenograft failure: Relevance to clinical organ xenotransplantation - Review articleJustification of specific genetic modifications in pigs for clinical organ xenotransplantationEpisodes of hypovolemia/dehydration in baboons with pig kidney transplants: A new syndrome of clinical importance?Fluid intake and output in baboons
P50
Q33438583-8DE9F995-29FE-4F6A-BD08-BB12550273DBQ36153588-98B1AA41-8A5C-453E-AF68-43D43498E3D4Q36288984-C450FF91-6722-441E-AFBF-B3FD8264D146Q36687035-F34B4083-4ADF-4916-A0F3-3C5ED087BFC4Q37176206-5C7FA0B4-E222-4142-94D3-8EFEF124B504Q37365004-983AD8B0-6613-4261-B3FF-E6E5920EE0FCQ38231549-9BA34151-DFF7-4744-AC84-545F3BC08B93Q40100407-4F3A21DF-D5F5-4C4F-BD28-872FEF2E4743Q40346878-A42067CB-B42E-454D-ADC6-DB9E5D4D92B1Q40588660-30B56B11-260C-4E3A-8BCC-40AA51209558Q41033597-B78C6BE8-042A-49CA-A455-1D91AE86AE17Q44632269-C999531F-A5E5-44F0-BBB2-E1FFF74134B8Q47778948-1A4A2A66-73BB-4A7F-BA8E-8D0113EC59F6Q50237087-60DAFEAE-08F9-43A1-9163-E6649BE2A5FEQ50276822-D08846A1-E949-425B-999B-060667555569Q50278148-8B7AA90F-2C2B-4D06-9E09-067B7F5FF43BQ50474692-129EB72A-293B-4321-95FD-7E0A79BC8D3AQ50476173-26A23C9B-BAB7-495A-AFE8-B8F8D2C9250DQ50489400-B76AB8EB-5754-4A91-974E-FC79C5C38FA3Q50507367-94509816-BACC-4A4A-AD11-617A93A71249Q50517603-8554D910-4F83-4F78-9B4F-6D57A02A8A2EQ50535364-F336F1C8-9E65-4206-825D-01F5EA2606DDQ50535369-11C178C1-551E-40FA-88B7-B635362AAE63Q56890337-F93B1B57-BFED-449D-9B89-518D2E418956Q87623462-5F1ADF91-A7D0-400F-B54E-41E151A5D2BCQ88228692-71A43F09-1F32-4931-A1B4-98A1B1A7C769Q88327370-9DDBE9A0-8603-4ACE-B573-1D339C8FEB0EQ90309617-1EA23E7A-7353-47C4-8606-6660856039BEQ91304719-98A3A792-BBFA-4FAD-BC4E-18BDD91296E0Q92839100-623EA693-1050-42BC-8A22-DCE66366CE44Q93120238-46E83F3C-1463-4ED5-A4AA-CB016A10617FQ93370007-C1CC22C9-3BF9-44F2-B6FB-4FEF73A63323Q94455962-398621EB-F424-424F-816C-49FBD0A333CF
P50
description
researcher
@en
հետազոտող
@hy
name
Takayuki Yamamoto
@ast
Takayuki Yamamoto
@en
Takayuki Yamamoto
@es
Takayuki Yamamoto
@nl
Takayuki Yamamoto
@sl
تاكايوكي ياماموتو
@ar
type
label
Takayuki Yamamoto
@ast
Takayuki Yamamoto
@en
Takayuki Yamamoto
@es
Takayuki Yamamoto
@nl
Takayuki Yamamoto
@sl
تاكايوكي ياماموتو
@ar
prefLabel
Takayuki Yamamoto
@ast
Takayuki Yamamoto
@en
Takayuki Yamamoto
@es
Takayuki Yamamoto
@nl
Takayuki Yamamoto
@sl
تاكايوكي ياماموتو
@ar
P108
P106
P108
P1153
55624472470
P31
P496
0000-0001-8216-0750